5 employees
Forty51 Ventures is the Biotech Venture Capital.
2022
Mosanna Therapeutics raised undisclosed on April 11, 2023
Investors: Supermoon Capital, High-Tech Gründerfonds and Forty51 Ventures
Mosanna Therapeutics raised undisclosed on July 13, 2022
Investors: Forty51 Ventures